Vaccine Improvement Patent Awarded to iBio
May 04, 2015 08:31 ET | iBio, Inc.
NEW YORK, NY--(Marketwired - May 4, 2015) - iBio, Inc. (NYSE MKT: IBIO) a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a...
iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics
April 27, 2015 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Apr 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio's...
iBio European Plague Vaccine Patent Emerges From Opposition Period
March 30, 2015 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Mar 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), today announced it received notice from the European Patent Office that the opposition period expired for a bio-defense...
iBio Adds Anthrax Antibodies to Product Pipeline
February 25, 2015 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Feb 25, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of US...
iBio Receives US and European Patents for Protein Expression Technology
February 12, 2015 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
iBio Adds to iBioModulator Portfolio and Product Pipeline
February 04, 2015 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting
December 10, 2014 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...
iBio Grants Caliber License for Production of Antibodies Targeting Ebola
November 10, 2014 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
iBio Expands Exclusive Product Collaboration With Novici Biotech
October 22, 2014 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
October 16, 2014 08:31 ET | iBio, Inc.
NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...